Aprea Therapeutics Common stock (APRE) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.92
-0.81
-0.69
-0.58

Details

Expected EPS
-0.716433
Actual EPS
-0.64
Surprise EPS
0.08
Surprise Percent
+10.67%

Description

Aprea Therapeutics Common stock (APRE) has reported earnings of -0.64 per share for Q4 2024.

0 Comments

Share your thoughts